Member Info for Spikeyj

"There are no performance criteria attached to the above options."

nicely. (not tempting fate, am i, lol?)

no amazing powers of deduction needed for you. you are pretty obvious.

Astrazeneca rallied after Jefferies upgraded the stock to 'buy' from 'hold' and lifted the price target to 5,800p from 5,400p. The broker said it sees a much higher probability of success and larger market opportunity from the MYSTIC study than consensus implies.

(although many of those posts have also been deleted this am)

i think he has recently sold some or all of his IMTK stake and has bought into a few other AIM stocks which he wanted to ramp up instead. (e.g. cloudtag where it looks like he bought into a spike early sept.) several of those posts on this board and others have been deleted already, presumably as too off-topic. he also started posting up again on the WTG board, where i think he still holds a significant chunk which are a long way underwater. numerous posters there have also recognised him as another avatar of brotherh.

miker, it's not just about the nature of the target asset, it's also about the price that has to be paid for it. i don't think jap / jo / amanda actually hold any shares in this company yet, do they? (very happy to read different information if i've overlooked a holdings RNS etc.) so it will be interesting to see at what strike price they incentivise themselves if / as / when they conclude some kind of deal. they will make sure they lock in personal gain from a deal at any level.

no prediction i'd care to share, thanks. my interest has mainly been rob terry, which seems history here.

of trampling on strawberries, and somewhat overblown metaphors. somewhat reminiscent of the dearly departed brotherhumble.

this one seemed quite encouraging ... 08-Sep-16 12:09:40 39.07 515,700 Buy* 38.00 39.00 201.48k O

yes, it's a bit double-edged. seems to provide some reassurance no more hideous short-falls lurking in closet known but not yet announced, but also unlikely imminent new contracts. i prefer the BoD buying more, than not!

just one self-confessed 'employee' (well, founder) so far? (i don't think onthemoney has claimed to be an ex, has he?)

remains a fairly restful share. family appears to be getting on.

(or am i being too cynical?)

certain amount of recent movement connected with shifting £/$ rates, especially recent short-covering? hard to know longer term what a clinton administration would actually do.. all parties like to talk tough and shake big stick at popular fall guys (which includes big pharma) in election campaigns, 'cos it's what joe and juanita public want to hear. once the votes are actually cast, politicians may or may not follow up on pledges. depends if they think it will cost.

& decent broker upgrade. (.. if only the latter meant anything...)

attempt by BoD to reassure.

no prob, and no offence meant. you're certainly right that JLG have lots of different projects on the go around the world, so there is some *geographical* diversification built in. but on the whole they are fairly confined to certain sorts of investment, as you say infrastructure. the management here have expertise in that rather limited, specialist field. whereas WRN, if they are to be believed, has claimed it was aiming at substantial diversification across different *sectors*, which is in theory more a conglomerate. (obviously, a major, major difference is that there are some well audited, public, clear descriptions of what assets JLG actually has, & some audited public valuations of these.) if you like this one for a medium or longer view, provi is possibly also worth a look on same time scale, although it's gone up a chunk recently so it would not be surprising to see +/- £2 in short term. provi also likely to have decent dependable growth even in gloomy global growth climate (tho' like any financial would not be immune to total bank collapse!!) gl.

personally, i find it very hard to see what kind of different ventures wrn actually has, (if any!) since there's so little evidence & fact out there in public domain. but off-topic here! atb.

hiya timenott, welcome to the party, & gl. probably not the sort of company to produce sudden leaps forward or do any exciting multi-bagging, but seems to have a decent pipeline of reasonable growth opportunities, & relatively secure income streams compared to many. as per my previous comments, several BoD buy-ins. (tbh can't say i see any resemblance whatsoever between here & WRN, but perhaps that's just my lack of imagination!)